Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo

Cancer

Breast cancer cell

How Cancer Stem Cells Drive Triple-Negative Breast Cancer

Discovery of mechanistic links may lead to new therapies

Microscope
February 15, 2018/Cancer

Molecular Biomarkers and Lung Cancer Risk Prediction and Early Detection

Accuracy does not equal clinical utility

LiverTransProt-Fig-1
January 18, 2018/Cancer

First Transplant to Treat Liver Metastases from Colorectal Cancer in the U.S.

New protocol may lead to improved patient outcomes

650×450-Patient-Consult-Prostate
January 17, 2018/Cancer

Quality of Life Study in Early Prostate Cancer Shows Neoadjuvant Androgen Deprivation Therapy May Not Improve Quality of Life

Negative affect reported in several sexuality-related functions at two years

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ahluwalia, MD
January 15, 2018/Cancer

Survival Benefit of Adjunctive Tumor-Treating Fields Therapy Confirmed in Glioblastoma

First new medical intervention in a decade to demonstrate improved survival

counseling_650x450
January 5, 2018/Cancer/Patient Support

Fear of Recurrence Common Among Breast Cancer Survivors

Providers can help prevent or minimize the trauma

statins_650x450
January 4, 2018/Cancer/Research

Statins Inhibit In Vitro Growth and Increase Radiation Sensitivity of Colorectal Cancer Cells

Cardiovascular drug affects cancer cell protein pathways

Lab_650x450
January 3, 2018/Cancer/Research

Next-Generation Sequencing of Tumor Tissue Versus Blood in Patients with Advanced Urothelial Cancer

Study examines concordance between commercially available genomic tests

Funchain_650x450
December 13, 2017/Cancer/Patient Support

Familial Melanoma Registry Aims to Close Knowledge Gaps and Empower Patients

Melanoma may be more heritable than we think

maciejewski_650x450
December 11, 2017/Cancer/Research

Exploiting Vulnerability of Impaired DNA Repair Creates New Therapeutic Strategy in Acute Myeloid Leukemia

Cleveland Clinic researchers first to show sensitivity of IDH1/2 mutations to PARP inhibitor olaparib

BackPage 85 of 91Next

Advertisement

Ad